US10881663 — Method of treating pain in elderly patients with mild renal impairment
Method of Use · Assigned to Baudax Bio Inc · Expires 2039-03-08 · 13y remaining
What this patent protects
This patent protects a method of treating pain in elderly patients with mild renal impairment by administering meloxicam intravenously.
USPTO Abstract
The present disclosure relates to administration of meloxicam intravenously, for treatment of pain, in patients who are at least 65 years old and have mild renal impairment, which can provide fast onset of pain relief suitable for management of acute pain as well as moderate to severe pain.
Drugs covered by this patent
- Mobic (MELOXICAM) · Boehringer Ingelheim
FDA Patent Use Codes
When a patent is method-of-use, FDA lists it once per applicable indication ("U-code"). Each U-code carves out a specific therapeutic use that generic filers must either license or design around.
| Code | Description | Drug |
|---|---|---|
U-3038 |
— | Mobic |
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.